Success Metrics

Clinical Success Rate
83.3%

Based on 5 completed trials

Completion Rate
83%(5/6)
Active Trials
0(0%)
Results Posted
20%(1 trials)
Terminated
1(10%)

Phase Distribution

Ph early_phase_1
1
10%
Ph not_applicable
9
90%

Phase Distribution

1

Early Stage

0

Mid Stage

0

Late Stage

Phase Distribution10 total trials
Early Phase 1First-in-human
1(10.0%)
N/ANon-phased studies
9(90.0%)

Highest Phase Reached

Early Phase 1

Trial Status & Enrollment

Completion Rate

71.4%

5 of 7 finished

Non-Completion Rate

28.6%

2 ended early

Currently Active

0

trials recruiting

Total Trials

10

all time

Status Distribution
Completed(5)
Terminated(2)
Other(3)

Detailed Status

Completed5
unknown3
Withdrawn1
Terminated1

Development Timeline

Analytics

Development Status

Total Trials
10
Active
0
Success Rate
83.3%
Most Advanced
Early Phase 1

Trials by Phase

Early Phase 11 (10.0%)
N/A9 (90.0%)

Trials by Status

withdrawn110%
completed550%
unknown330%
terminated110%

Recent Activity

Clinical Trials (10)

Drug Details

Intervention Type
PROCEDURE
Total Trials
10